Milestones
Hadassah researchers-initiated Phase I/II
(MS & ALS – 34 Patients)
2005
2010
Published results of Phase I/II
Published Long term Study results (MS – 28 Patients)
2012
2015
Initiated Phase IIA – Progressive MS (48 Patients)
Initiated compassionate treatments (MS , ALS)
Received EU patent
Company established - License from Hadasit & Seed capital
Phase IIB - Unprecedented Interim Results
2018
2019
Publish Phase IIB results – ECTRIMS 2019 Conference